Biofrontera Inc. Common Stock (BFRI)
Biofrontera Inc. Common Stock
XNAS:BFRI
0.86
$1.01 - 42.00
$0.71 - 500.00
$0.82
$0.89
$0.89
$0.9
1.2
0.54
177792
119939.9
9948075.53
Chart
TendieTensor AI Analysis
Company
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.
Fundamentals
93
-0.470000
-3.876700
100
BBG00HTD0PX0
BBG00HTD0PY9
10.14M
10.67M
Technicals
Short Interest
—
—
—
Higher = harder to cover
—
Prev: —
—
—
5D avg: —
—
Discussion
Login to participate in discussions.
Recent News
Related Stocks
Based on the portfolios of people who own BFRI. This is a list generated by trading data from 3rd party trading platforms, and it's not a recommendation.